Literature DB >> 19220298

Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders.

Hirotaka Nakahashi1, Norifumi Tsukamoto, Yoko Hashimoto, Hiromi Koiso, Akihiko Yokohama, Takayuki Saitoh, Hideki Uchiumi, Hiroshi Handa, Hirokazu Murakami, Yoshihisa Nojima, Masamitsu Karasawa.   

Abstract

The incidence of chronic lymphocytic leukemia is low in the Japanese population compared with populations in western countries, suggesting a role for genetic factors in the occurrence of this disease. We have previously shown that chronic lymphocytic leukemia in Japan rarely expresses the immunoglobulin heavy chain variable region (IGHV) 1-69 gene (1 out of 43 patients, 2.3%), which is a gene most commonly expressed in chronic lymphocytic leukemia cases from western countries. In the current study, we extended the previous study by examining immunoglobulin heavy chain and light chain gene expression in 80 Japanese patients with chronic lymphocytic leukemia and in 52 Japanese patients with other leukemic chronic lymphoproliferative disorders. IGHV1-69 gene expression was again quite low in our cohort, found in only two patients: one with chronic lymphocytic leukemia and the other with splenic marginal zone lymphoma. The IGHV4-34 gene was most frequently expressed in chronic lymphocytic leukemia (27.5%), whereas it was rarely found in leukemic chronic lymphoproliferative disorders (7.7%, P = 0.005). There was also a significant difference in the expression of IGLV3-21 between chronic lymphocytic leukemia and leukemic chronic lymphoproliferative disorders (29.4 vs 4.8%, P = 0.018). The IGLV3-21 gene in the majority of chronic lymphocytic leukemia cases was associated with homologous complementarity determining region 3 sequences. Recent studies identified subsets of cases expressing almost identical B-cell receptors. We found that two patients with chronic lymphocytic leukemia and the patient with splenic marginal zone lymphoma expressed IGHV4-39/IGKV1-39 and IGHV1-69/IGKV3-20, respectively, which belong to these subsets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220298     DOI: 10.1111/j.1349-7006.2009.01092.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  5 in total

1.  SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.

Authors:  Takeki Mitsui; Hiromi Koiso; Hirotaka Nakahashi; Akio Saitoh; Hiroaki Shimizu; Takuma Ishizaki; Yoshiyuki Ogawa; Makiko Takizawa; Akihiko Yokohama; Takayuki Saitoh; Takahiro Jinbo; Hidemi Ogura; Hiroshi Handa; Morio Sawamura; Tohru Sakura; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

2.  Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia.

Authors:  Ying-Jung Huang; Ming-Chung Kuo; Hung Chang; Po-Nan Wang; Jin-Hou Wu; Yen-Min Huang; Ming-Chun Ma; Tzung-Chih Tang; Ching-Yuan Kuo; Lee-Yung Shih
Journal:  Br J Haematol       Date:  2019-06-23       Impact factor: 6.998

3.  Genetic differences between Asian and Caucasian chronic lymphocytic leukemia.

Authors:  Norihiko Kawamata; Chimene Moreilhon; Takayuki Saitoh; Masamitsu Karasawa; Brian K Bernstein; Aiko Sato-Otsubo; Seishi Ogawa; Sophie Raynaud; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2013-05-27       Impact factor: 5.650

4.  Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia.

Authors:  Marilisa Marinelli; Caterina Ilari; Yi Xia; Ilaria Del Giudice; Luciana Cafforio; Irene Della Starza; Sara Raponi; Paola Mariglia; Silvia Bonina; Zhen Yu; Wenjuan Yang; Lugui Qiu; Thomas Chan; Alfonso Piciocchi; Yok-Lam Kwong; Eric Tse; Jianyong Li; Anna Guarini; Wei Xu; Robin Foà
Journal:  Oncotarget       Date:  2016-04-12

5.  IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling.

Authors:  Palash C Maity; Mayas Bilal; Marvyn T Koning; Marc Young; Cornelis A M van Bergen; Valerio Renna; Antonella Nicolò; Moumita Datta; Eva Gentner-Göbel; Rob S Barendse; Sebastiaan F Somers; Ruben A L de Groen; Joost S P Vermaat; Daniela Steinbrecher; Christof Schneider; Eugen Tausch; Tamara Bittolo; Riccardo Bomben; Andrea Nicola Mazzarello; Giovanni Del Poeta; Wilma G M Kroes; J Tom van Wezel; Katharina Imkeller; Christian E Busse; Massimo Degano; Tamam Bakchoul; Axel Ronald Schulz; Henrik Mei; Paolo Ghia; Konstantia Kotta; Kostas Stamatopoulos; Hedda Wardemann; Antonella Zucchetto; Nicholas Chiorazzi; Valter Gattei; Stephan Stilgenbauer; Hendrik Veelken; Hassan Jumaa
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-11       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.